Facing CAR T Cell Challenges on the Deadliest Paediatric Brain Tumours
Authors:
- Cristina FerrerasCFCristina Ferreras
- Lucía FernándezLFLucía Fernández
- Laura Clares-VillaLCLaura Clares-Villa
- Marta Ibáñez-NavarroMIMarta Ibáñez-Navarro
- Carla Martín-CortázarCMCarla Martín-Cortázar
- Isabel Esteban-RodríguezIEIsabel Esteban-Rodríguez
- Javier SacedaJSJavier Saceda
- Antonio Pérez-MartínezAntonio Pérez-Martínez
Open Access
Abstract
Central nervous system (CNS) tumours comprise 25% of the paediatric cancer diagnoses and are the leading cause of cancer-related death in children. Current treatments for paediatric CNS tumours are far from optimal and fail for those that relapsed or are refractory to treatment. Besides, long-term sequelae in the developing brain make it mandatory to find new innovative approaches. Chimeric antigen receptor T cell (CAR T) therapy has increased survival in patients with B-cell malignancies, but the intrinsic biological characteristics of CNS tumours hamper their success. The location, heterogeneous antigen expression, limited infiltration of T cells into the tumour, the selective trafficking provided by the blood–brain barrier, and the immunosuppressive tumour microenvironment have emerged as the main hurdles that need to be overcome for the success of CAR T cell therapy. In this review, we will focus mainly on the characteristics of the deadliest high-grade CNS paediatric tumours (medulloblastoma, ependymoma, and high-grade gliomas) and the potential of CAR T cell therapy to increase survival and patients’ quality of life.Keywords
This publication has 223 references indexed in Scilit:
- In vitro Natural Killer Cell Immunotherapy for MedulloblastomaFrontiers in Oncology, 2013
- Mesenchymal Transition and PDGFRA Amplification/Mutation Are Key Distinct Oncogenic Events in Pediatric Diffuse Intrinsic Pontine GliomasPLOS ONE, 2012
- Pediatric High Grade Glioma: a Review and Update on Tumor Clinical Characteristics and BiologyFrontiers in Oncology, 2012
- Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastomaBlood, 2011
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer ImmunotherapyClinical Cancer Research, 2011
- Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiformeJournal of Neuro-Oncology, 2010
- Integrated Molecular Genetic Profiling of Pediatric High-Grade Gliomas Reveals Key Differences With the Adult DiseaseJournal of Clinical Oncology, 2010
- Lack of Efficacy of Bevacizumab Plus Irinotecan in Children With Recurrent Malignant Glioma and Diffuse Brainstem Glioma: A Pediatric Brain Tumor Consortium StudyJournal of Clinical Oncology, 2010
- Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomasJournal of Neuro-Oncology, 2008
- Stem Cell–like Glioma Cells Promote Tumor Angiogenesis through Vascular Endothelial Growth FactorCancer Research, 2006